Behind the 10,000-Pharmacy Network: How Kim Byung-joo Built Korea’s Med-Tech Giant
"What exactly is unfolding in today’s pharmacy ecosystem?" Starting from a corporate R&D background and community practice, CEO Kim Byung-joo transformed Charmpharm into a medical-tech enterprise spanning over 700 locations, with its "Banpharm" inventory platform used by nearly 40% of South Korean pharmacies. Driven by digital transformation, field data, and deeply human patient care, he is advancing from streamlined inventory to global K-pharmaceutical care.
TikTok and Kearney's K-Culture Report: What the USD 30.4 Billion Number Actually Measures
TikTok Korea and the consulting firm Kearney published a study on 26 August 2026 estimating that K-culture on TikTok will be worth USD 30.4 billion by 2030, with K-beauty the largest of six sectors on direct economic impact at USD 2.45 billion. The headline is already circulating through the Korean beauty industry as though it were a market size. It is not one — it is a sum that adds consumer spending outside Korea to a modelled multiplier inside Korea.
APS Innovation Buys Irae: Why K-Beauty's Real Bottleneck Is Line Changeover, Not Formulation
A KOSDAQ-listed maker of secondary-battery and display equipment has bought a cosmetics filling-and-packaging automation company for USD 17.7 million, in a deal brokered by a Korean state credit-guarantee fund. It is a small transaction, and it describes where the K-beauty industry's constraint actually sits far better than the export figures do. The thing that stops an indie brand scaling into a new market is almost never the formulation. It is the filling line.
LG H&H Sells Avon North America to Regent for $6 Million: What the Price Actually Measures
LG Household & Health Care agreed to sell Avon North America to Regent affiliate Stratford Worldwide for $6M—a sharp drop from the $330M invested since 2019 ($125M purchase + $205.5M loan). The low price doesn't mark the death of direct selling, as model expansion elsewhere shows. Instead, it reveals that a brand name and its underlying representative seller network are separate assets, with real value lying in the distribution machine itself.
Korea's Cosmetics Industry Promotion Act: Who the "Innovative Cosmetics Company" Certification Will Actually Reward
Korea's National Assembly passed the Act on the Fostering and Support of the Cosmetics Industry on 20 August 2026. The only genuinely new instrument in it — certification as an "innovative cosmetics company" — has its qualifying thresholds left entirely to presidential decree. That means the law that decides who benefits will be written over the next twelve months, not last week, and if it is written as an R&D-spending gate it will certify the manufacturers and miss the expor
Estée Lauder's Dr.Jart+ Writedown: What a Strategic Exit Actually Buys a Korean Founder
Estée Lauder wrote USD 375 million off Dr.Jart+ in fiscal 2025, then ran a sale process for the brand, took bids, and decided in July 2026 to keep it and shrink the team instead. The company's fiscal 2026 results, published on 19 August 2026, name Dr.Jart+ in exactly two places. This is the clearest public record of what happens to a Korean brand after the exit everyone treats as the finish line.
K-Brand Certification Mark: Why Korea's Anti-Counterfeit System Concedes That Nobody Owns "K-Beauty"
The Korean Intellectual Property Office is registering a K-Brand certification mark in 70 export countries and holding the rights itself. That choice of legal instrument is the argument: a certification mark exists precisely because the thing being protected belongs to a whole class of producers rather than to any one of them. This piece sets out why "K-beauty" is a country-of-origin commons rather than brand equity, and what a Korean exporter actually owns once the adjective
